Trial intelligence / Profile preview

Juvenile lupus nephritis cyclophosphamide regimen comparison trial

2005-003957-28Phase 3Completed

Sponsor
Istituto Giannina Gaslini
Start
May 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of cyclophosphamide in juvenile systemic lupus erythematosus (JSLE) and lupus nephritis (LN) (3 arms), sponsored by Istituto Giannina Gaslini. Started May 2006; status: completed.

02

Drugs

cyclophosphamide
03

Conditions

juvenile systemic lupus erythematosus (JSLE)lupus nephritis (LN)

Beyond the preview

Go deeper on 2005-003957-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003957-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call